Abstract
Six rats were trained to discriminate the effects of LSD (100 μg/kg) and saline in a two-lever choice task. They were then tested with each of three phenethylamine derivatives, BL-3912 (2,5-dimethoxy-4-methyl-α-ethyl-phenethylamine), fenfluramine (N-ethyl-α-methyl-m-(trifluoro-methyl)phenethylamine), and Sch-12679 (N-methyl-1-phenyl-7,8-dimethoxy-2,3,4,5-tetra-hydro-3-benzazepine maleate). Fenfluramine and Sch-12679 yielded intermediate results, i.e., responding was not fully appropriate for either training condition while BL-3912 substituted completely for LSD. The LSD-like effects of each of the drugs were antagonized by pretreatment with BC-105, a serotonergic antagonist known to block the stimulus effects of indole and phenethylamine hallucinogens. The present data together with consideration of the known clinical effects of BL-3912, fenfluramine, and Sch-12679 are consistent with the following conclusions: (1) a variety of drugs may substitute in whole or in part for LSD in LSD-trained rats, and (2) even complete substitution of a drug for LSD in the rat is not necessarily associated with the production by that drug of hallucinations in man.
Similar content being viewed by others
References
Albert, J. M., Elie, R., Cooper, S. F., Clermont, A., Langloris, Y.: Efficacy of Sch-12679 in the management of aggressive mental retardates. Curr. Ther. Res. Clin. Exp. 21, 786–795 (1977)
Appel, J. B., White, F. J., Kuhn, D. M.: The use of discriminative stimuli in behavioral pharmacodynamics. First Int. Sym. Drugs as Discriminative Stimuli. Beerse, Belgium, 1978
Barnett, A., Taber, R. I., Steiner, S. S.: The behavioral pharmacology of Sch-12679, a new psychoactive agent. Psychopharmacologia 36, 281–290 (1974)
Browne, R. G., Ho, B. T.: The role of serotonin in the discriminative stimulus properties of mescaline. Pharmacol. Biochem. Behav. 3, 429–435 (1975)
Goldstein, A.: Biostatistics. New York, London: MacMillan 1964
Goudie, A. J.: Discriminative stimulus properties of fenfluramine in an operant task: An analysis of its cue function. Psychopharmacology 53, 97–102 (1977)
Griffith, J. D., Nutt, J. G., Jasinski, D. R.: A comparison of fenfluramine and amphetamine in man. Clin. Pharmacol. Ther. 18, 563–570 (1975)
Hirschhorn, I. D., Rosecrans, J. A.: A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD). Pharmacol. Biochem. Behav. 3, 361–366 (1974)
Hirschhorn, I. D., Winter, J. C.: Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia 22, 64–71 (1971)
Hirschhorn, I. D., Winter, J. C.: Differences in the stimulus properties of barbital and hallucinogens. Pharmacol. Biochem. Behav. 3, 343–347 (1975)
Itil, T. M., Stock, M. J., Duffy, A. D., Esquenazi, A., Saluety, B., Han, T. H.: Therapeutic trials and EEG investigations with Sch-12679 in behaviorally disturbed adolescents. Curr. Ther. Res. Clin. Exp. 14, 136–150 (1972)
Jasinski, D. R., Gilbert, P. E., Vaupel, D. B., Risner, M. E., Cone, E. J.: Progress report from NIDA Addiction Research Center. Proc. 40th Annu. Sci. Mtg., Comm. on Problems of Drug Dependence, pp. 151–182, 1978
Jespersen, S., Bonaccorsi, A.: Effect of fenfluramine on the d-amphetamine toxicity in mice. Eur. J. Pharmacol. 8, 364–368 (1969)
Keskiner, A., Itil, T. M., Han, T. H., Saletu, B., Hsu, W.: Clinical toxicological and electroencephalographic study with Sch-12679 in chronic schizophrenics. Curr. Ther. Res. Clin. Exp. 13, 714–725 (1971)
Kuhn, D. M., White, F. J., Appel, J. B.: Discriminative stimulus properties of hallucinogens: Behavioral assay of drug action. In: Discriminative stimulus properties of drugs, H. Lal, ed., pp. 137–154. New York: Plenum Press 1977
Kuhn, D. M., White, F. J., Appel, J. B.: The discriminative stimulus properties of LSD: Mechanisms of action. Neuropharmacology 17, 257–263 (1978)
LaPierre, Y. D.: Effectiveness of Sch-12679, a benzazepine, in the treatment of anxiety neurosis. Curr. Ther. Res. Clin. Exp. 24, 204–208 (1978)
Levin, A.: The non-medical misuse of fenfluramine by drug-dependent young South Africans. Postgrad. Med. J. [Suppl.] 51, 186–188 (1975)
Martin, W. R., Vaupel, D. B., Nozaki, M., Bright, L. D.: The identification of LSD-like hallucinogens using the chronic spinal dog. Drug Alcohol Depend. 3, 113–123 (1978)
Mullen, A., Wilson, C. W. M., Wilson, B. P. M.: Dreaming, fenfluramine, and vitamin C. Br. Med. J. 1, 70–72 (1977)
Park, S., Gershon, S., Floyd, A.: A clinical trial of a benzazepine (Sch-12679) in acute schizophrenic patients. Curr. Ther. Res. Clin. Exp. 14, 298–302 (1972)
Schechter, M. D., Rosecrans, J. A.: Lysergic acid diethylamide (LSD) as a discriminative cue: Drugs with similar stimulus properties. Psychopharmacologia 26, 313–316 (1972)
Silverman, P. B., Ho, B. T.: Stimulus properties of DOM: Commonality with other hallucinogens. In: Stimulus properties of drugs: ten years of progress, F. C. Colpaert, J. A. Rosecrans, eds., pp. 189–198. Amsterdam: Elsevier 1978
Snyder, S. H., Weingartner, H., Faillace, L. A.: DOET (2,5-dimethoxy-4-ethyl-amphetamine), a new psychotropic drug. Effects of varying doses in man. Arch. Gen. Psychiatry 24, 50–55 (1971)
Tilson, H. A., Chamberlain, J. H., Gylys, J. A.: Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane with R-DOM and S-amphetamine. Psychopharmacology 51, 169–173 (1977a)
Tilson, H. A., Chamberlain, J. H., Gylys, J. A.: Further studies on BL-3912A: Effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock. Pharmacol. Biochem. Behav. 6, 627–630 (1977b)
White, F. J., Appel, J. B., Kuhn, D. M.: Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacol. 18, 143–151 (1979)
White, F. J., Kuhn, D. M., Appel, J. B.: Discriminative stimulus properties of quipazine. Neuropharmacol. 16, 827–832 (1977)
Winer, B. J.: Statistical principles in experimental design. New York, London: McGraw-Hill 1971
Winter, J. C.: A comparison of the stimulus properties of mescaline and 2,3,4-trimethoxyphenylethylamine. J. Pharmacol. Exp. Ther. 185, 101–107 (1973)
Winter, J. C.: Blockade of the stimulus properties of mescaline by a serotonin antagonist. Arch. Int. Pharmacodyn. Ther. 214, 250–253 (1975a)
Winter, J. C.: The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethyxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus. Psychopharmacologia 44, 29–32 (1975b)
Winter, J. C.: Drug-induced stimulus control. In: Contemporary research in behavioral pharmacology, D. E. Blackman, D. J. Sanger, eds., pp. 209–245. New York: Plenum Press 1978a
Winter, J. C.: Stimulus properties of phenethylamine hallucinogens and LSD: The role of 5-hydroxytryptamine. J. Pharmacol. Exp. Ther. 204, 416–423 (1978b)
Winter, J. C.: Quipazine-induced stimulus control in the rat. Psychopharmacology 60, 265–269 (1979)
Yelnosky, J., Lawlor, R. B.: A comparative study of the pharmacologic actions of amphetamine and fenfluramine. Arch. Int. Pharmacodyn. Ther. 184, 374–388 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winter, J.C. Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus. Psychopharmacology 68, 159–162 (1980). https://doi.org/10.1007/BF00432134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432134